{"id":"W4394780042","doi":"10.1093/ecco-jcc/jjae038","title":"Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme","year":2024,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada); Western University; McGill University Health Centre","funders":"Allergan; Genentech; KU Leuven; Pfizer Canada; Universiteit van Amsterdam; Silverback Therapeutics; Celltrion; Teva Pharmaceutical Industries; Gilead Sciences; Mylan; Celgene; Biogen; GlaxoSmithKline; Amgen; Dr. Falk Pharma; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Proctitis; Ulcerative colitis; Placebo; Internal medicine; Gastroenterology; Clinical endpoint; Post-hoc analysis; Clinical trial; Colitis; Inflammatory bowel disease; Phases of clinical research; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002749286,0.0001087487,0.0001833791,0.00003311678,0.0000374236,0.00005599305,0.00008092679,0.00008786222,0.000003372364],"category_scores_gemma":[0.0001582667,0.00007118777,0.00004719358,0.00007442176,0.00008476529,0.00001563698,0.00004171124,0.0001708083,4.259443e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001335449,"about_ca_system_score_gemma":0.0001855517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002264032,"about_ca_topic_score_gemma":0.00007347902,"domain_scores_codex":[0.9989614,0.0001023339,0.0004510665,0.0001934885,0.0001381403,0.0001535419],"domain_scores_gemma":[0.9993194,0.00006451258,0.0001596756,0.0001102206,0.000205291,0.0001408368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8026764,0.001213831,0.01501222,0.00009644229,0.0008769477,0.0007718698,0.001436414,0.00007850439,0.0002651399,0.00009616395,0.001139371,0.1763367],"study_design_scores_gemma":[0.006905338,0.001641733,0.9880804,0.0002189235,0.00005627287,0.00001130163,0.00007174185,0.0001030329,0.0003258568,0.00005870682,0.002429102,0.00009753695],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998632,0.0002194581,0.0001019555,0.0002268104,0.00006358316,0.0003740026,0.0003195746,0.000002723302,0.00005988282],"genre_scores_gemma":[0.9994248,0.0001499233,0.0001423125,0.0001160021,0.000100286,0.000004930891,0.00002816648,0.00001233494,0.0000212542],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9730682,"threshold_uncertainty_score":0.2902953,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01222658706844179,"score_gpt":0.2854720386708682,"score_spread":0.2732454516024265,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}